Fed. Circ. Pauses PTAB Review Of Restasis Patents
The Federal Circuit on Wednesday ordered the Patent Trial and Appeal Board to pause its review of patents covering Allergan PLC's dry eye medication Restasis while the appeals court considers arguments...To view the full article, register now.
Already a subscriber? Click here to view full article